Renhe Pharmacy announced that its share buyback plan through centralized competitive bidding has been fully implemented. A total of 17.7 million shares were repurchased, accounting for 1.2643 percent of the company's total share capital, with a total transaction amount of approximately 99.9996 million yuan. The buyback was carried out between April 28, 2026 and August 5, 2026, with the highest transaction price at 5.73 yuan per share and the lowest at 4.86 yuan per share. The company had previously planned to use its own funds of 80 million to 150 million yuan to repurchase shares for future equity incentives or employee stock ownership plans, with a buyback price not exceeding 8.00 yuan per share. The repurchased shares are temporarily held in the company's dedicated buyback securities account. If not fully granted within 36 months after the completion of the buyback, the ungranted shares will be fully cancelled.
Renhe Pharmacy Co LtdCompany completed its share buyback plan, signaling confidence and supporting share price.
